Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials recruiting in Idaho

Fewer than 3 recruiting trials found.

All Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials nationally

Cities in Idaho

Recruiting trials in Idaho

• A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
  NCT07063745 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Idaho: Boise